Media Doctor Canada
Follow us on Twitter








"Vaccine against cervical cancer approved"

Globe and Mail

Source: Globe and Mail

Published: 19 Jul 2022

Category: Pharmaceutical

Rating: (3 stars)

what they said (Hover the mouse cursor over underlined words for more info)

Health Canada has given its approval to the first vaccine that can protect women from most cases of cervical cancer.

But the cost, about $400, will likely prove an impediment to its widespread use.

The vaccine, called Gardasil, protects against four types of human papillomavirus, a common sexually transmitted disease that can cause cancer of the cervix, vulva and vagina, and is also the cause of some genital warts....

The original article can found in the Media Doctor archives.

how did it rate? (more information)

Criteria Rating
Total Score 6 of 10
Availability of Treatment Satisfactory (?)
Novelty of Treatment Satisfactory (?)
Disease Mongering Satisfactory (?)
Treatment Options Satisfactory (?)
Costs of Treatment Satisfactory (?)
Evidence Not Satisfactory (?)
Quantification of Benefits of Treatment Not Satisfactory (?)
Harms of Treatment Not Satisfactory (?)
Sources of Information Satisfactory (?)
Relies on Press Release Not Applicable
Quantification of Harms of Treatment Not Satisfactory (?)

what we said (Hover the mouse cursor over underlined words for more info)

This relatively well-written article describes the pending Canadian availability of a new vaccine that is expected to reduce the incidence of papilloma virus-associated cervical, vulvar and vaginal cancer. While the information provided is generally accurate, the article lacks some important detail regarding the clinical trials completed and quantitative information on the clinical benefits derived. No information regarding potential harms is provided, and the unknown sustained benefit (including need for boosters) is somewhat under-emphasized. Cost (unqualified) is identified as a significant issue, but no specific reference to cost-benefit (potential or otherwise) is provided. It is critical that readers are aware that the new vaccine augments but does not replace regular Pap tests, and that the vaccine needs to be given before becoming sexually active (and potentially exposed to the virus) to be effective. Credit is given to the author for including these important messages.

Readers interested in analysis of reports of cervical cancer vaccines in the UK should take a look at the report in Hitting the Headlines at:

public forum

There are currently no comments on this article.

voice your opinion in the forum

  • All comments and feedback submitted to Media Doctor are subject to editorial approval before being made viewable by the public. It may take up to a week for your comments to be approved. Additionally, no response will be given to questions posed in public comments. Media Doctor does not provide medical advice, or answers to medical questions posed by the public.
  • If you provide your email address it will not be displayed to the general public.
  • Comments may be edited by Media Doctor to remove defamatory or sensitive statements, and brand names.
  • Required fields are marked with an asterisk (*).
Name: *
Comments: *
Copyright © Media Doctor Canada